×
About 13,382 results

ALLMedicine™ Pruritus Center

Research & Reviews  5,527 results

Neurokinin 1 Receptor Antagonists for Pruritus.
https://doi.org/10.1007/s40265-021-01478-1 10.1038/nrn1950 10.1016/j.jaci.2018.09.005 10.1155/2018/5742753 10.1159/000446010 10.1111/exd.14071 10.1111/jdv.15973 10.1097/j.pain.0000000000001551 10.3389/fnins.2019.01262 10.1113/jphysiol.1931.sp002763 10.1152/physrev.00031.2013 10.4049/jimmunol.1601751 10.1001/archderm.139.11.1479 10.1111/imr.12635 10.1371/journal.pone.0227817 10.1111/bjd.18025 10.4049/jimmunol.166.2.1285 10.1111/j.1600-0625.1998.tb00307.x 10.1016/j.sder.2011.04.001 10.1007/s00281-018-0675-z 10.1002/ejp.767 10.1038/72247 10.2340/00015555-2780 10.1038/jid.2014.226 10.1111/j.1365-2133.2011.10241.x 10.1016/j.jid.2017.12.029 10.1111/j.1749-6632.2011.05961.x 10.1056/NEJMc0906670 10.1016/j.jaad.2011.12.021 10.1111/dth.12113 10.1016/j.ad.2013.07.007 10.1016/j.jaad.2011.01.016 10.1001/jamadermatol.2018.2510 10.1056/NEJMc1003937 10.1016/S1470-2045(12)70373-X 10.1007/s00520-010-0895-9 10.1016/S1474-4422(18)30217-5 10.1371/journal.pone.0010968 10.1001/archdermatol.2012.1018 10.1056/NEJMc1013027 10.1007/s00403-014-1451-0 10.1111/jdv.15905 10.2340/00015555-3120 10.1001/jamadermatol.2013.170 10.5021/ad.2016.28.1.124 10.1186/1752-1947-8-300 10.1016/j.sder.2011.05.002 10.1056/NEJMra074081 10.1542/pir.2016-0169 10.2340/00015555-2852 10.1080/08923973.2018.1558235 10.1016/j.juro.2010.03.147 10.1016/j.jaad.2019.01.052 10.1016/j.jaad.2020.01.056 10.1111/bjd.19496 10.1016/j.jaad.2019.09.014 10.1016/j.bmc.2013.09.001 10.1177/0269881113480990 10.1111/exd.12528 10.1136/bmjopen-2019-030114 10.1007/s13555-019-0305-2 10.1172/jci.insight.89362 10.1038/s41467-019-08568-5
Drugs Alam M, Buddenkotte J et. al.

Mar 6th, 2021 - Pruritus, commonly known as itch, is a very common symptom in numerous dermatological disorders and systemic diseases. It can manifest as acute, or when lasting longer than 6 weeks, it is considered chronic and can lead to significant distress and...

IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors a...
https://doi.org/10.1016/j.annonc.2021.02.016
Annals of Oncology : Official Journal of the European Soc... Barrios DM, Phillips GS et. al.

Mar 5th, 2021 - Immunoglobulin E (IgE) blockade with omalizumab has demonstrated clinical benefit in pruritus-associated dermatoses (e.g., atopic dermatitis, bullous pemphigoid, urticaria). In oncology, pruritus-associated cutaneous adverse events (paCAEs) are fr...

Progressive Familial Intrahepatic Cholestasis Associated With USP53 Gene Mutation in a ...
https://doi.org/10.1097/MPG.0000000000003110
Journal of Pediatric Gastroenterology and Nutrition; Porta G, Rigo PSM et. al.

Mar 4th, 2021 - A case of low-GGT cholestasis associated to USP53 gene mutation in a Brazilian child is described. Transient jaundice and hypocholia started at age 10 days old. Liver enzymes, total bilirubin and total bile acids were elevated at presentation. Dur...

Synergic Effect of Botulinum Toxin Type-A and Triamcinolone Alleviates Scar Pruritus By...
https://doi.org/10.1093/asj/sjab105
Aesthetic Surgery Journal; Huang SH, Wu KW et. al.

Mar 4th, 2021 - Patients often experience scar-related pruritus, which negatively affects quality of life. Triamcinolone acetonide (TAC) is widely used to treat pathological scars, and botulinum toxin type-A (BTX-A) reportedly improves scarring and associated dis...

Critical Care Management of the Patient With Anaphylaxis: A Concise Definitive Review.
https://doi.org/10.1097/CCM.0000000000004893
Critical Care Medicine; Krishnaswamy G

Mar 3rd, 2021 - Anaphylaxis is a rapidly progressive life-threatening syndrome manifesting as pruritus, urticaria, angioedema, bronchospasm and shock. The goal of this synthetic review is to provide a practical, updated approach to the evaluation and management o...

see more →

Guidelines  19 results

Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic cholestasis of pre...
https://doi.org/10.1016/j.ajog.2020.11.002
American Journal of Obstetrics and Gynecology; , Lee RH et. al.

Nov 16th, 2020 - Intrahepatic cholestasis of pregnancy is a hepatic disorder characterized by pruritus and an elevation in serum bile acid levels. Although intrahepatic cholestasis of pregnancy poses little risk for women, this condition carries a significant risk...

Diagnosis and Management of Vulvar Skin Disorders: ACOG Practice Bulletin Summary, Numb...
https://doi.org/10.1097/AOG.0000000000003945
Obstetrics and Gynecology;

Jun 26th, 2020 - Vulvar skin disorders include a variety of inflammatory conditions of the vulva that also may affect the extragenital area. Pruritus and pain are two of the most common presenting symptoms in vulvar clinics (). Vulvovaginal symptoms often are chro...

Diagnosis and Management of Vulvar Skin Disorders: ACOG Practice Bulletin, Number 224.
https://doi.org/10.1097/AOG.0000000000003944
Obstetrics and Gynecology;

Jun 26th, 2020 - Vulvar skin disorders include a variety of inflammatory conditions of the vulva that also may affect the extragenital area. Pruritus and pain are two of the most common presenting symptoms in vulvar clinics (). Vulvovaginal symptoms often are chro...

Nail Changes Following a Viral Infection: Photo Quiz
https://www.aafp.org/afp/2019/1015/p497.html
American Family Physician;

Oct 14th, 2019 - A seven-year-old boy presented with abnormal growth of his fingernails that began two weeks prior. He had no other symptoms, including pain or pruritus on his hands or around his nails. He did not have fevers, chills, nausea, vomiting, or change i...

Pruritus (PDQ®)–Health Professional Version
https://www.cancer.gov/about-cancer/treatment/side-effects/skin-nail-changes/pruritus-hp-pdq

Aug 12th, 2019 - Pruritus (itching of the skin) can be a complication of cancer or its treatment. Get detailed information about the etiology, assessment, and interventions for pruritus in this summary for clinicians.

see more →

Drugs  737 results see all →

Clinicaltrials.gov  6,531 results

Neurokinin 1 Receptor Antagonists for Pruritus.
https://doi.org/10.1007/s40265-021-01478-1 10.1038/nrn1950 10.1016/j.jaci.2018.09.005 10.1155/2018/5742753 10.1159/000446010 10.1111/exd.14071 10.1111/jdv.15973 10.1097/j.pain.0000000000001551 10.3389/fnins.2019.01262 10.1113/jphysiol.1931.sp002763 10.1152/physrev.00031.2013 10.4049/jimmunol.1601751 10.1001/archderm.139.11.1479 10.1111/imr.12635 10.1371/journal.pone.0227817 10.1111/bjd.18025 10.4049/jimmunol.166.2.1285 10.1111/j.1600-0625.1998.tb00307.x 10.1016/j.sder.2011.04.001 10.1007/s00281-018-0675-z 10.1002/ejp.767 10.1038/72247 10.2340/00015555-2780 10.1038/jid.2014.226 10.1111/j.1365-2133.2011.10241.x 10.1016/j.jid.2017.12.029 10.1111/j.1749-6632.2011.05961.x 10.1056/NEJMc0906670 10.1016/j.jaad.2011.12.021 10.1111/dth.12113 10.1016/j.ad.2013.07.007 10.1016/j.jaad.2011.01.016 10.1001/jamadermatol.2018.2510 10.1056/NEJMc1003937 10.1016/S1470-2045(12)70373-X 10.1007/s00520-010-0895-9 10.1016/S1474-4422(18)30217-5 10.1371/journal.pone.0010968 10.1001/archdermatol.2012.1018 10.1056/NEJMc1013027 10.1007/s00403-014-1451-0 10.1111/jdv.15905 10.2340/00015555-3120 10.1001/jamadermatol.2013.170 10.5021/ad.2016.28.1.124 10.1186/1752-1947-8-300 10.1016/j.sder.2011.05.002 10.1056/NEJMra074081 10.1542/pir.2016-0169 10.2340/00015555-2852 10.1080/08923973.2018.1558235 10.1016/j.juro.2010.03.147 10.1016/j.jaad.2019.01.052 10.1016/j.jaad.2020.01.056 10.1111/bjd.19496 10.1016/j.jaad.2019.09.014 10.1016/j.bmc.2013.09.001 10.1177/0269881113480990 10.1111/exd.12528 10.1136/bmjopen-2019-030114 10.1007/s13555-019-0305-2 10.1172/jci.insight.89362 10.1038/s41467-019-08568-5
Drugs Alam M, Buddenkotte J et. al.

Mar 6th, 2021 - Pruritus, commonly known as itch, is a very common symptom in numerous dermatological disorders and systemic diseases. It can manifest as acute, or when lasting longer than 6 weeks, it is considered chronic and can lead to significant distress and...

IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors a...
https://doi.org/10.1016/j.annonc.2021.02.016
Annals of Oncology : Official Journal of the European Soc... Barrios DM, Phillips GS et. al.

Mar 5th, 2021 - Immunoglobulin E (IgE) blockade with omalizumab has demonstrated clinical benefit in pruritus-associated dermatoses (e.g., atopic dermatitis, bullous pemphigoid, urticaria). In oncology, pruritus-associated cutaneous adverse events (paCAEs) are fr...

Progressive Familial Intrahepatic Cholestasis Associated With USP53 Gene Mutation in a ...
https://doi.org/10.1097/MPG.0000000000003110
Journal of Pediatric Gastroenterology and Nutrition; Porta G, Rigo PSM et. al.

Mar 4th, 2021 - A case of low-GGT cholestasis associated to USP53 gene mutation in a Brazilian child is described. Transient jaundice and hypocholia started at age 10 days old. Liver enzymes, total bilirubin and total bile acids were elevated at presentation. Dur...

Synergic Effect of Botulinum Toxin Type-A and Triamcinolone Alleviates Scar Pruritus By...
https://doi.org/10.1093/asj/sjab105
Aesthetic Surgery Journal; Huang SH, Wu KW et. al.

Mar 4th, 2021 - Patients often experience scar-related pruritus, which negatively affects quality of life. Triamcinolone acetonide (TAC) is widely used to treat pathological scars, and botulinum toxin type-A (BTX-A) reportedly improves scarring and associated dis...

Critical Care Management of the Patient With Anaphylaxis: A Concise Definitive Review.
https://doi.org/10.1097/CCM.0000000000004893
Critical Care Medicine; Krishnaswamy G

Mar 3rd, 2021 - Anaphylaxis is a rapidly progressive life-threatening syndrome manifesting as pruritus, urticaria, angioedema, bronchospasm and shock. The goal of this synthetic review is to provide a practical, updated approach to the evaluation and management o...

see more →

News  561 results

Fast Five Quiz: Atopic Dermatitis and Type 2 Cytokines
https://reference.medscape.com/viewarticle/944891

Mar 2nd, 2021 - Atopic dermatitis is a chronic inflammatory skin condition characterized by pruritus, erythema, lichenification, and excoriation. These clinical manifestations result in an impaired quality of life, especially in patients with moderate to severe d...

Dupilumab Curbed Itch Intensity, Frequency in Children With Severe Eczema
https://www.medscape.com/viewarticle/943807

Jan 7th, 2021 - Dupilumab treatment with concomitant topical corticosteroids provided rapid and sustained improvement in itch intensity and frequency in children aged 6-11 years with severe atopic dermatitis. Dr Gil Yosipovitch The findings come from a post hoc a...

Study: Doctors Underreport Side Effects of Breast Irradiation
https://www.medscape.com/viewarticle/943289

Dec 28th, 2020 - There is a substantial mismatch between patient and physician reports of toxicity during radiotherapy for breast cancer, according to an analysis of nearly 10,000 U.S. patients. Researchers assessed physician underrecognition of four key symptoms ...

Antihistamine Prescribing for AD Varies by Specialty
https://www.medscape.com/viewarticle/942699

Dec 14th, 2020 - Dermatologists are more likely than are nondermatologists to follow practice guidelines when prescribing antihistamines to treat pruritus associated with atopic dermatitis (AD), according to an analysis of a national database.   The American Acade...

Bezafibrate Improves Itch in Patients With Cholestatic Diseases
https://www.staging.medscape.com/viewarticle/940403

Nov 4th, 2020 - (Reuters Health) - Patients with moderate to severe primary or secondary sclerosing cholangitis experienced greater reduction of pruritis with bezafibrate than with placebo, a small trial found. Researchers examined data on 44 patients with primar...

see more →

Patient Education  7 results see all →